Brain Diseases  >>  Cerebrolysin (porcine brain-derived proteolytic peptide fraction)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
CERE-LYSE-1, NCT00840671 / 2004-001729-11: Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

Completed
3
119
Europe, RoW
Cerebrolysin, 0.9% Saline Solution, NaCl
Ever Neuro Pharma GmbH, JSW-Research Forschungslabor GmbH, Parkring 12, 8074 Grambach
Stroke
03/08
07/08
CIB-NBS-C, NCT01388738: Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Completed
3
30
RoW
citicoline, L-Alpha glycerylphosphorylcholine, cerebrolysin
Clinical Institute of the Brain, Russia, Nycomed, Veropharm, Ever Neuro Pharma GmbH
Stroke
10/11
11/11

Download Options